EE232 Impact of Updated Mortality Estimates on the Cost-Effectiveness of Rifaximin for the Treatment of Patients with Overt Hepatic Encephalopathy von Bhattacharyya, S., John, D., Thomas, A., Soni, P., Jesudian, A.B., Dashputre, A.A., Joseph, G.

Volltext

234 THE ROLE OF SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) IN HEPATIC ENCEPHALOPATHY von Weisberg, I.S, Jesudian, A.B, Barboza, K.C, Liu, T, Bosworth, B.P, Sigal, S.H

Volltext